SCOPUS 정보 검색 플랫폼

Studies in Health Technology and Informatics

Volumn 173, Issue , 2012, Pages 457-462

Virtual trainer for intra-detrusor injection of botulinum toxin to treat urinary incontinence

(8) Shen, Yunhe a,b Vasandani, Pankaj a Iyer, Jayesh a Gunasekaran, Arjune a Zhang, Yingchun b Burke, Daniel a,b Dykstra, Dennis a Sweet, Robert a,b

a UNIVERSITY OF MINNESOTA (United States)

b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL (United States)

Author keywords

Bladder; Botulinum toxin; Incontinence; Surgical training; Virtual reality

Indexed keywords

TOXIC MATERIALS; VIRTUAL REALITY;

BLADDER; BOTULINUM TOXINS; INCONTINENCE; LEARNING MANAGEMENTS; SIMULATION SYSTEMS; SURGICAL TRAINING; TRAINING SYSTEMS; URINARY INCONTINENCE;

INFORMATION MANAGEMENT;

BOTULINUM ANTISERUM;

ARTICLE; AUDIOVISUAL EQUIPMENT; COMPUTER INTERFACE; COMPUTER SIMULATION; ELASTOGRAPHY; FEMALE; HUMAN; MALE; OVERACTIVE BLADDER; URINE INCONTINENCE;

BOTULINUM ANTITOXIN; COMPUTER SIMULATION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; MALE; MODELS, ANATOMIC; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE; USER-COMPUTER INTERFACE;

EID: 84860612027 PISSN: 09269630 EISSN: 18798365 Source Type: Book Series
DOI: 10.3233/978-1-61499-022-2-457 Document Type: Conference Paper

Times cited : (4)

References (11)

1
- 80052268776
- Efficacy and safety of onabotulinumtoxina in patients with urinary incontinence due to neurogenic detrusor overactivity
- Vienna, Austria. March
- Francisco Cruz, Sender Herschorn, Philip Aliotta, Mitchell Brin, Catherine Thompson, Wayne Lam, Grace Daniell, John Heesakkers, Cornelia Haag-Molkenteller: Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity, 26th Annual European Association of Urology Congress, Vienna, Austria. March 2011.
- (2011) 26th Annual European Association of Urology Congress
- Cruz, F.¹ Herschorn, S.² Aliotta, P.³ Brin, M.⁴ Thompson, C.⁵ Lam, W.⁶ Daniell, G.⁷ Heesakkers, J.⁸ Haag-Molkenteller, C.⁹

2
- 79953044039
- Laser surgery simulation platform: Toward full procedure training and rehearsal for benign prostatic hyperplasia (BPH) therapy
- Y. Shen, V. Konchada, N. Zhang, S. Jain, X. Zhou, D. Burke, C. Wong, C. Carson, C. Roehrborn and R. Sweet. Laser surgery simulation platform: Toward full procedure training and rehearsal for benign prostatic hyperplasia (BPH) therapy. Studies in Health Technology and Informatics, Vol. 163, pp. 574-580, 2011.
- (2011) Studies in Health Technology and Informatics , vol.163 , pp. 574-580
- Shen, Y.¹ Konchada, V.² Zhang, N.³ Jain, S.⁴ Zhou, X.⁵ Burke, D.⁶ Wong, C.⁷ Carson, C.⁸ Roehrborn, C.⁹ Sweet, R.¹⁰

3
- 84872456640
- http://www.prodelphus.com/websiteEnglish/products/show.asp?prdCode= 8CD66A54-6A97-4531-8DA7-F027343CEEEC&layerID=1

4
- 78349305456
- Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: A doubleblind, placebo controlled, randomized, dose ranging trial
- Dmochowski R, Chapple C, Nitti VW, et al. Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a doubleblind, placebo controlled, randomized, dose ranging trial. J Urol 184:2416-22, 2010.
- (2010) J Urol , vol.184 , pp. 2416-2422
- Dmochowski, R.¹ Chapple, C.² Nitti, V.W.³

5
- 79959996667
- Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder
- AlTaweel W, Mokhtar A, Rabah DM. Prospective randomized trial of 100u vs 200u botox in the treatment of idiopathic overactive bladder. Urol Ann 2011; 3:66-70
- (2011) Urol Ann , vol.3 , pp. 66-70
- Altaweel, W.¹ Mokhtar, A.² Rabah, D.M.³

6
- 84872464162
- ClinicalTrials.gov Id: NCT00583219 : December 20, 2007 Last Updated: March 14
- ClinicalTrials.gov Id: NCT00583219 Study Title: Botulin-A Toxin Instillations and Overactive Bladder First Received: December 20, 2007 Last Updated: March 14, 2011
- (2011) Study Title: Botulin-A Toxin Instillations and Overactive Bladder First Received

7
- 84872456406
- Manufactured by: Allergan Pharmaceuticals Ireland a subsidiary of: Allergan, Inc. 2525 Dupont Dr., Irvine, CA 92612
- Botox® (onabotulinumtoxinA) for injection. Manufactured by: Allergan Pharmaceuticals Ireland a subsidiary of: Allergan, Inc. 2525 Dupont Dr., Irvine, CA 92612
- Botox® (OnabotulinumtoxinA) for Injection

8
- 84872476532
- http://www.inition.co.uk/inition/news-botox.htm

9
- 78149257636
- Volumetric modeling in laser BPH therapy simulation
- N. Zhang, X. Zhou, Y. Shen and R. Sweet. Volumetric Modeling in Laser BPH Therapy Simulation. IEEE Trans. on Visualization and Computer Graphics, Vol. 16-6, pp. 1405-1412, 2010.
- (2010) IEEE Trans. on Visualization and Computer Graphics , vol.16 , Issue.6 , pp. 1405-1412
- Zhang, N.¹ Zhou, X.² Shen, Y.³ Sweet, R.⁴

10
- 20444459051
- Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: Results of a single treatment, randomized, placebo controlled 6-month study
- Schurch B, De Seze M, Denys P, et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study, 174:196-200, J Urol 2005.
- (2005) J Urol , vol.174 , pp. 196-200
- Schurch, B.¹ De Seze, M.² Denys, P.³

11
- 84855598973
- August 25
- FDA approves Botox to treat specific form of urinary incontinence. FDA News Release, August 25, 2011. http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/ucm269509.htm
- (2011) FDA Approves Botox to Treat Specific Form of Urinary Incontinence

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.